WASOG Conference 2022

WASOG Conference 2022 WASOG Conference will take place this year, on November 14-17 in Sibiu, Romania

๐Ÿ”ฅ๐Ÿ”ฅ๐ˆ๐ง๐ญ๐ž๐ซ๐š๐œ๐ญ๐ข๐ฏ๐ž ๐œ๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐œ๐š๐ฌ๐ž๐ฌ โ€“ โ€œ๐‹๐ฎ๐ง๐ ๐ฌ ๐จ๐ง ๐Ÿ๐ข๐ซ๐žโ€ ๐ฌ๐ž๐ฌ๐ฌ๐ข๐จ๐ง ๐ข๐ฌ ๐จ๐ง! Radu Crisan, Claudiu Iordache, Ionela Belaconi, Tudor Cons...
17/11/2022

๐Ÿ”ฅ๐Ÿ”ฅ๐ˆ๐ง๐ญ๐ž๐ซ๐š๐œ๐ญ๐ข๐ฏ๐ž ๐œ๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐œ๐š๐ฌ๐ž๐ฌ โ€“ โ€œ๐‹๐ฎ๐ง๐ ๐ฌ ๐จ๐ง ๐Ÿ๐ข๐ซ๐žโ€ ๐ฌ๐ž๐ฌ๐ฌ๐ข๐จ๐ง ๐ข๐ฌ ๐จ๐ง!

Radu Crisan, Claudiu Iordache, Ionela Belaconi, Tudor Constantinescu and Daniel Traila presented their interesting cases and Irina Strรขmbu, Ulrich Costabel, Daniel Trฤƒilฤƒ discussed together all these cases.
We thank our chairs: Tudor Constantinescu and Dragos Bumbacea.

We end the WASOG Conference with satisfaction and the joy that we had the chance to meet in Romania and get updated with the latest news from our field.

๐Ÿ”ธSystemic diseases and ILDs session started with ๐Š๐š๐ญ๐ž๐ซ๐ข๐ง๐š ๐€๐ง๐ญ๐จ๐ง๐ข๐จ๐ฎ followed by ๐€๐ง๐ง๐š โ€“ ๐Œ๐š๐ซ๐ข๐š ๐‡๐จ๐Ÿ๐Ÿ๐ฆ๐š๐ง๐ง โ€“ ๐•๐จ๐ฅ๐ and their pe...
17/11/2022

๐Ÿ”ธSystemic diseases and ILDs session started with ๐Š๐š๐ญ๐ž๐ซ๐ข๐ง๐š ๐€๐ง๐ญ๐จ๐ง๐ข๐จ๐ฎ followed by ๐€๐ง๐ง๐š โ€“ ๐Œ๐š๐ซ๐ข๐š ๐‡๐จ๐Ÿ๐Ÿ๐ฆ๐š๐ง๐ง โ€“ ๐•๐จ๐ฅ๐ and their perspective on CTD-ILDs.
๐Œ๐ข๐ฅ๐ž๐ง๐š ๐Œ๐š๐ง introduced us to the subject of Antisynthetase syndrome.

Very comprehensive presentations with a lot of useful information.
Thank you Katerina Antoniou, Anna-Maria Hoffmann, Milena Man and our chairs: Ionela Belaconi and Athol Wells.

๐Ÿ—ฃLast day of WASOG Conference started with a session dedicated to ILDs and more. ๐…๐ซ๐š๐ง๐œ๐ž๐ฌ๐œ๐จ ๐๐จ๐ง๐ž๐ฅ๐ฅ๐š joined us online and...
17/11/2022

๐Ÿ—ฃLast day of WASOG Conference started with a session dedicated to ILDs and more.
๐…๐ซ๐š๐ง๐œ๐ž๐ฌ๐œ๐จ ๐๐จ๐ง๐ž๐ฅ๐ฅ๐š joined us online and talked about the Pulmonary Alveolar Proteinosis: on the verge of a breakthrough.
๐“๐ฎ๐๐จ๐ซ ๐‚๐จ๐ง๐ฌ๐ญ๐š๐ง๐ญ๐ข๐ง๐ž๐ฌ๐œ๐ฎ went on with a talk on ILDs and pulmonary hypertension.
Non-pharmacological treatments ILDs were revealed by ๐€๐ฅ๐ž๐ฑ๐š๐ง๐๐ซ๐ฎ ๐‚๐ซ๐ข๐ฌฬฆ๐š๐ง and ๐ƒ๐ซ๐š๐ ๐จ๐ฌ ๐๐ฎ๐ฆ๐›๐š๐œ๐ž๐š touched a very interesting subject, Lung transplant for ILDs.

The session was chaired by Daniel Trฤƒilฤƒ and Antigona Trofor.

๐ŸŽ–๐€๐ฌ๐ญ๐ซ๐š ๐™๐ž๐ง๐ž๐œ๐š is our gold exhibitor at WASOG Conference. We are grateful for the beautiful collaboration and thankful fo...
17/11/2022

๐ŸŽ–๐€๐ฌ๐ญ๐ซ๐š ๐™๐ž๐ง๐ž๐œ๐š is our gold exhibitor at WASOG Conference.
We are grateful for the beautiful collaboration and thankful for the support they offered in the organization of the event.
Find out more about Astra Zeneca on ๐Ÿ‘‰ https://www.astrazeneca.com/

๐Ÿ”ธSecond session of sarcoidosis of the day. ๐ƒ๐š๐ง ๐‚๐ฎ๐ฅ๐ฏ๐ž๐ซ opened the discussion on Extrapulmonary sarcoidosis, followed by ๐‘...
16/11/2022

๐Ÿ”ธSecond session of sarcoidosis of the day.
๐ƒ๐š๐ง ๐‚๐ฎ๐ฅ๐ฏ๐ž๐ซ opened the discussion on Extrapulmonary sarcoidosis, followed by ๐‘๐จ๐›๐ž๐ซ๐ญ ๐๐š๐ฎ๐ ๐ก๐ฆ๐š๐ง with his two presentations: Diagnosis: when biopsy is not needed, New treatments in sarcoidosis.
Thank you all for this amazing day, see you tomorrow, starting with 8.30 am. ๐Ÿค—

Pharma session - ๐Š๐ข๐ง๐ž๐ฏ๐š๐ง๐ญ symposium with ๐Š๐ข๐ฒ๐จ๐ฆ๐ข ๐Š๐จ๐ฆ๐จ๐ซ๐ข and Robert Baughman from USA and their speech on the evaluation o...
16/11/2022

Pharma session - ๐Š๐ข๐ง๐ž๐ฏ๐š๐ง๐ญ symposium with ๐Š๐ข๐ฒ๐จ๐ฆ๐ข ๐Š๐จ๐ฆ๐จ๐ซ๐ข and Robert Baughman from USA and their speech on the evaluation of an Anti-GM-CSF Monoclonal Antibody (Namilumab) in a Phase 2 Pulmonary Sarcoidosis Trial.
The session was chaired by ๐ˆ๐ซ๐ข๐ง๐š ๐’๐ญ๐ซ๐š๐ฆ๐›๐ฎ.

Thank you Kinevant for all the support and for being our gold partner!

Hypersensitivity pneumonitis session is on!๐Ÿ”ฅ๐Œ๐š๐ซ๐ญ๐ข๐ง๐š ๐Š๐จ๐ณ๐ข๐š๐ซ -๐•๐š๐ฌ๐š๐ค๐จ๐ฏ๐š, an expert of HP, introduced us to the subject with...
16/11/2022

Hypersensitivity pneumonitis session is on!๐Ÿ”ฅ
๐Œ๐š๐ซ๐ญ๐ข๐ง๐š ๐Š๐จ๐ณ๐ข๐š๐ซ -๐•๐š๐ฌ๐š๐ค๐จ๐ฏ๐š, an expert of HP, introduced us to the subject with her presentation "Practical approach to diagnosis and treatment of HP in the light of new guidelines."
๐”๐ฅ๐ซ๐ข๐œ๐ก ๐‚๐จ๐ฌ๐ญ๐š๐›๐ž๐ฅ joined us online and talked about BAL in HP (and other ILDs). ๐ƒ๐ข๐š๐ง๐š ๐Ž๐ญฬฆ๐ž๐ฅ๐ž๐š went on with her discussion on Occupational ILDs.

Poster discussion on sarcoidosis.
16/11/2022

Poster discussion on sarcoidosis.

Poster discussion on sarcoidosis. ๐Ÿ–ฅ
16/11/2022

Poster discussion on sarcoidosis. ๐Ÿ–ฅ

๐Ÿ”ธSarcoidosis session, on third day of WASOG Conference. ๐ˆ๐ซ๐ข๐ง๐š ๐’๐ญ๐ซ๐šฬ‚๐ฆ๐›๐ฎ started the session talking about the New guideli...
16/11/2022

๐Ÿ”ธSarcoidosis session, on third day of WASOG Conference.
๐ˆ๐ซ๐ข๐ง๐š ๐’๐ญ๐ซ๐šฬ‚๐ฆ๐›๐ฎ started the session talking about the New guidelines in sarcoidosis and was followed by ๐‡๐ž๐ฅ๐ฆ๐ฎ๐ญ ๐๐ซ๐จ๐ฌ๐œ๐ก with his talk on CT patterns in sarcoidosis.
Last but not least, ๐Œ๐š๐ซ๐ฃ๐จ๐ฅ๐ž๐ข๐ง ๐ƒ๐ซ๐ž๐ง๐ญ offered a very comprehensive speech on Impact and limitations of sarcoidosis.

See you after the lunch break with poster session.

๐ŸงฌThe day continued with Astra Zeneca Pharma Symposium about Re โ€“ evaluating mortality in COPD, performed by ๐ˆ๐ซ๐ข๐ง๐š ๐’๐ญ๐ซ๐šฬ‚๐ฆ...
16/11/2022

๐ŸงฌThe day continued with Astra Zeneca Pharma Symposium about Re โ€“ evaluating mortality in COPD, performed by ๐ˆ๐ซ๐ข๐ง๐š ๐’๐ญ๐ซ๐šฬ‚๐ฆ๐›๐ฎ.
Thank you Astra Zeneca for the beautiful collaboration and for the support.

๐Ÿ“ฃThird day of WASOG Conference just started with a session dedicated to ILDs and post Covid with ๐Œ๐š๐ซ๐ข๐š ๐Œ๐จ๐ฅ๐ข๐ง๐š ๐Œ๐จ๐ฅ๐ข๐ง๐š and...
16/11/2022

๐Ÿ“ฃThird day of WASOG Conference just started with a session dedicated to ILDs and post Covid with ๐Œ๐š๐ซ๐ข๐š ๐Œ๐จ๐ฅ๐ข๐ง๐š ๐Œ๐จ๐ฅ๐ข๐ง๐š and her presentation on ERS Task Force on Post-Covid ILDs.
๐‚๐ฅ๐š๐ฎ๐๐ข๐š ๐‘๐š๐ฏ๐š๐ ๐ฅ๐ข๐š continued with an overview on Clinical, morphological and radiological features of Post-covid ILDs. Afterwards, ๐ƒ๐ข๐š๐ง๐š ๐Œ๐š๐ง๐จ๐ฅ๐ž๐ฌ๐œ๐ฎ revealed the Romanian perspective on Post-Covid ILD. ๐Ž๐ฏ๐ข๐๐ข๐ฎ ๐…๐ข๐ซ๐š ๐Œ๐ฅ๐šฬ†๐๐ข๐ง๐ž๐ฌ๐œ๐ฎ ended the session with this perspective on Telemedicine and Covid-19.
๐Ÿ”ธThe session was chaired by Wim Wuyts and Antigona Trofor.
๐Ÿ”ธFantastic points of view and presentations!

๐Ÿงฌ๐๐ก๐š๐ซ๐ฆ๐š ๐๐จ๐ž๐ก๐ซ๐ข๐ง๐ ๐ž๐ซ - ๐ˆ๐ง๐ ๐ž๐ฅ๐ก๐ž๐ข๐ฆ ๐๐ซ๐จ๐ ๐ซ๐ž๐ฌ๐ฌ๐ข๐ฏ๐ž ๐๐ฎ๐ฅ๐ฆ๐จ๐ง๐š๐ซ๐ฒ ๐…๐ข๐›๐ซ๐จ๐ฌ๐ข๐ฌ: ๐Œ๐ฒ๐ญ๐ก๐ฌ ๐š๐ง๐ ๐…๐š๐œ๐ญ๐ฌ ๐ฌ๐ฒ๐ฆ๐ฉ๐จ๐ฌ๐ข๐ฎ๐ฆ started with the introduction o...
15/11/2022

๐Ÿงฌ๐๐ก๐š๐ซ๐ฆ๐š ๐๐จ๐ž๐ก๐ซ๐ข๐ง๐ ๐ž๐ซ - ๐ˆ๐ง๐ ๐ž๐ฅ๐ก๐ž๐ข๐ฆ ๐๐ซ๐จ๐ ๐ซ๐ž๐ฌ๐ฌ๐ข๐ฏ๐ž ๐๐ฎ๐ฅ๐ฆ๐จ๐ง๐š๐ซ๐ฒ ๐…๐ข๐›๐ซ๐จ๐ฌ๐ข๐ฌ: ๐Œ๐ฒ๐ญ๐ก๐ฌ ๐š๐ง๐ ๐…๐š๐œ๐ญ๐ฌ ๐ฌ๐ฒ๐ฆ๐ฉ๐จ๐ฌ๐ข๐ฎ๐ฆ started with the introduction of ๐Œ๐š๐ซ๐ฅ๐ข๐ž๐ฌ ๐–๐ข๐ฃ๐ฌ๐ž๐ง๐›๐ž๐ž๐ค and the interactive presentation of ๐Œ๐š๐ซ๐ข๐š ๐Œ๐จ๐ฅ๐ข๐ง๐š ๐Œ๐จ๐ฅ๐ข๐ง๐š about the importance for the patients with ILD to receive an accurate differential diagnosis.
๐Œ๐š๐ซ๐ฅ๐ข๐ž๐ฌ ๐–๐ข๐ฃ๐ฌ๐ž๐ง๐›๐ž๐ž๐ค aimed to answer if: There are multiple drugs approved to treat PF ILD โ€“ Myth or fact? involving the participants through live voting.
The session was interactive and filled with important information for the future practice.
Thank you Boehringer Ingelheim, our platinum sponsor!

See you tomorrow, ready for another scientific day!

๐Ÿค“ILDs: Early diagnosis session started with ๐’๐š๐ซ๐š ๐“๐จ๐ฆ๐š๐ฌ๐ฌ๐ž๐ญ๐ญ๐ข and her presentation on Interstitial lung abnormalities. ๐–๐ข...
15/11/2022

๐Ÿค“ILDs: Early diagnosis session started with ๐’๐š๐ซ๐š ๐“๐จ๐ฆ๐š๐ฌ๐ฌ๐ž๐ญ๐ญ๐ข and her presentation on Interstitial lung abnormalities.
๐–๐ข๐ฆ ๐–๐ฎ๐ฒ๐ญ๐ฌ continued the session with his extensive knowledge on Early diagnosis for ILDs.

๐Ÿ‘จโ€โš•๏ธPatient organizations session welcomed Liam Galvin and Steve Jones from Ireland and also Robert Arsene from Romania,...
15/11/2022

๐Ÿ‘จโ€โš•๏ธPatient organizations session welcomed Liam Galvin and Steve Jones from Ireland and also Robert Arsene from Romania, who talked about the latest news on patient organizations and what is the perspective on the subject after COVID19 pandemic.

๐Ÿ–ฅ๐Ÿ‘€ The poster session just started with a lot of interest and curiosity for the cases.
15/11/2022

๐Ÿ–ฅ๐Ÿ‘€ The poster session just started with a lot of interest and curiosity for the cases.

๐ŸฅSecond day of WASOG Conference continued with a session on ๐ฉ๐ฎ๐ฅ๐ฆ๐จ๐ง๐š๐ซ๐ฒ ๐Ÿ๐ข๐›๐ซ๐จ๐ฌ๐ข๐ฌ. The session was opened by ๐€๐ณ๐ฎ๐ฆ๐š ๐€๐ซ๐š๐ญ๐š wi...
15/11/2022

๐ŸฅSecond day of WASOG Conference continued with a session on ๐ฉ๐ฎ๐ฅ๐ฆ๐จ๐ง๐š๐ซ๐ฒ ๐Ÿ๐ข๐›๐ซ๐จ๐ฌ๐ข๐ฌ.
The session was opened by ๐€๐ณ๐ฎ๐ฆ๐š ๐€๐ซ๐š๐ญ๐š with his presentation on Acute exacerbations in pulmonary fibrosis and was followed by ๐†๐š๐ง๐ž๐ฌ๐ก ๐‘๐š๐ ๐ก๐ฎ who talked about IPF diagnosis: guideline recommendations.
In the second part of the session, ๐€๐ญ๐ก๐จ๐ฅ ๐–๐ž๐ฅ๐ฅ๐ฌ offered the participants an answer to the question "Primary and secondary UIP: a unified diagnostic entity?" and ๐Œ๐š๐ซ๐ฅ๐ข๐ž๐ฌ ๐–๐ข๐ฃ๐ฌ๐ž๐ง๐›๐ž๐ž๐ค ended the session with a talk on the Advances in non-IPF pulmonary fibrosis.

๐Ÿ‘€Poster discussions coming after lunch break, stay tuned!

Address

Sibiu

Telephone

+40726268222

Website

Alerts

Be the first to know and let us send you an email when WASOG Conference 2022 posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category